FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer
Titel:
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer
Auteur:
Randrian, Violaine Pernot, Simon Le Malicot, Karine Catena, Vittorio Baumgaertner, Isabelle Tacher, Vania Forestier, Julien Hautefeuille, Vincent Tabouret-Viaud, Claire Gagnaire, Alice Mitry, Emmanuel Guiu, Boris Aparicio, Thomas Smith, Denis Dhomps, Anthony Tasu, Jean-Pierre Perdrisot, Rémy Edeline, Julien Capron, Claude Cheze-Le Rest, Catherine Emile, Jean-François Laurent-Puig, Pierre Bejan-Angoulvant, Theodora Sokol, Harry Lepage, Come Taieb, Julien Tougeron, David